International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease

David C. Fajgenbaum, Thomas S. Uldrick, Adam Bagg, Dale Frank, David Wu, Gordan Srkalovic, David Simpson, Amy Y. Liu, David Menke, Shanmuganathan Chandrakasan, Mary Jo Lechowicz, Raymond S.M. Wong, Sheila Pierson, Michele Paessler, Jean François Rossi, Makoto Ide, Jason Ruth, Michael Croglio, Alexander Suarez, Vera KrymskayaAmy Chadburn, Gisele Colleoni, Sunita Nasta, Raj Jayanthan, Christopher S. Nabel, Corey Casper, Angela Dispenzieri, Alexander Fosså, Dermot Kelleher, Razelle Kurzrock, Peter Voorhees, Ahmet Dogan, Kazuyuki Yoshizaki, Frits Van Rhee, Eric Oksenhendler, Elaine S. Jaffe, Kojo S.J. Elenitoba-Johnson, Megan S. Lim

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Human herpesvirus-8 (HHV-8)-negative, idiopathic multicentric Castleman disease (iMCD) is a rare and life-threatening disorder involving systemic inflammatory symptoms, polyclonal lymphoproliferation, cytopenias, and multiple organ system dysfunction caused by a cytokine storm often including interleukin-6. iMCD accounts for one third to one half of all cases ofMCDand can occur in individuals of any age. Accurate diagnosis is challenging, because no standard diagnostic criteria or diagnostic biomarkers currently exist, and there is significant overlap with malignant, autoimmune, and infectious disorders. An international working group comprising 34 pediatric and adult pathology and clinical experts in iMCD and related disorders from 8 countries, including 2 physicians that are also iMCD patients, was convened to establish iMCD diagnostic criteria. The working group reviewed data from 244 cases, met twice, and refined criteria over 15 months (June 2015 to September 2016). The proposed consensus criteria require both Major Criteria (characteristic lymph node histopathology and multicentric lymphadenopathy), at least 2 of 11Minor Criteria with at least 1 laboratory abnormality, and exclusion of infectious, malignant, and autoimmune disorders that can mimic iMCD. Characteristic histopathologic featuresmay include a constellation of regressed or hyperplastic germinal centers, follicular dendritic cell prominence, hypervascularization, and polytypic plasmacytosis. Laboratory and clinical Minor Criteria include elevatedC-reactive protein or erythrocyte sedimentation rate, anemia, thrombocytopenia or thrombocytosis, hypoalbuminemia, renal dysfunction or proteinuria, polyclonal hypergammaglobulinemia, constitutional symptoms, hepatosplenomegaly, effusions or edema, eruptive cherry hemangiomatosis or violaceous papules, and lymphocytic interstitial pneumonitis. iMCD consensus diagnostic criteria will facilitate consistent diagnosis, appropriate treatment, and collaborative research.

Original languageEnglish (US)
Pages (from-to)1646-1657
Number of pages12
JournalBlood
Volume129
Issue number12
DOIs
StatePublished - Mar 23 2017
Externally publishedYes

Fingerprint

Human Herpesvirus 8
Follicular Dendritic Cells
Hypergammaglobulinemia
Thrombocytosis
Hypoalbuminemia
Pediatrics
Clinical Pathology
Germinal Center
Blood Sedimentation
Interstitial Lung Diseases
Biomarkers
Pathology
Multi-centric Castleman's Disease
Proteinuria
Sedimentation
Thrombocytopenia
Anemia
Interleukin-6
Edema
Lymph Nodes

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Fajgenbaum, D. C., Uldrick, T. S., Bagg, A., Frank, D., Wu, D., Srkalovic, G., ... Lim, M. S. (2017). International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood, 129(12), 1646-1657. https://doi.org/10.1182/blood-2016-10-746933

International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. / Fajgenbaum, David C.; Uldrick, Thomas S.; Bagg, Adam; Frank, Dale; Wu, David; Srkalovic, Gordan; Simpson, David; Liu, Amy Y.; Menke, David; Chandrakasan, Shanmuganathan; Lechowicz, Mary Jo; Wong, Raymond S.M.; Pierson, Sheila; Paessler, Michele; Rossi, Jean François; Ide, Makoto; Ruth, Jason; Croglio, Michael; Suarez, Alexander; Krymskaya, Vera; Chadburn, Amy; Colleoni, Gisele; Nasta, Sunita; Jayanthan, Raj; Nabel, Christopher S.; Casper, Corey; Dispenzieri, Angela; Fosså, Alexander; Kelleher, Dermot; Kurzrock, Razelle; Voorhees, Peter; Dogan, Ahmet; Yoshizaki, Kazuyuki; Van Rhee, Frits; Oksenhendler, Eric; Jaffe, Elaine S.; Elenitoba-Johnson, Kojo S.J.; Lim, Megan S.

In: Blood, Vol. 129, No. 12, 23.03.2017, p. 1646-1657.

Research output: Contribution to journalArticle

Fajgenbaum, DC, Uldrick, TS, Bagg, A, Frank, D, Wu, D, Srkalovic, G, Simpson, D, Liu, AY, Menke, D, Chandrakasan, S, Lechowicz, MJ, Wong, RSM, Pierson, S, Paessler, M, Rossi, JF, Ide, M, Ruth, J, Croglio, M, Suarez, A, Krymskaya, V, Chadburn, A, Colleoni, G, Nasta, S, Jayanthan, R, Nabel, CS, Casper, C, Dispenzieri, A, Fosså, A, Kelleher, D, Kurzrock, R, Voorhees, P, Dogan, A, Yoshizaki, K, Van Rhee, F, Oksenhendler, E, Jaffe, ES, Elenitoba-Johnson, KSJ & Lim, MS 2017, 'International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease', Blood, vol. 129, no. 12, pp. 1646-1657. https://doi.org/10.1182/blood-2016-10-746933
Fajgenbaum, David C. ; Uldrick, Thomas S. ; Bagg, Adam ; Frank, Dale ; Wu, David ; Srkalovic, Gordan ; Simpson, David ; Liu, Amy Y. ; Menke, David ; Chandrakasan, Shanmuganathan ; Lechowicz, Mary Jo ; Wong, Raymond S.M. ; Pierson, Sheila ; Paessler, Michele ; Rossi, Jean François ; Ide, Makoto ; Ruth, Jason ; Croglio, Michael ; Suarez, Alexander ; Krymskaya, Vera ; Chadburn, Amy ; Colleoni, Gisele ; Nasta, Sunita ; Jayanthan, Raj ; Nabel, Christopher S. ; Casper, Corey ; Dispenzieri, Angela ; Fosså, Alexander ; Kelleher, Dermot ; Kurzrock, Razelle ; Voorhees, Peter ; Dogan, Ahmet ; Yoshizaki, Kazuyuki ; Van Rhee, Frits ; Oksenhendler, Eric ; Jaffe, Elaine S. ; Elenitoba-Johnson, Kojo S.J. ; Lim, Megan S. / International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. In: Blood. 2017 ; Vol. 129, No. 12. pp. 1646-1657.
@article{8c8bbaafa23b48d1a76cd972a3b99d64,
title = "International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease",
abstract = "Human herpesvirus-8 (HHV-8)-negative, idiopathic multicentric Castleman disease (iMCD) is a rare and life-threatening disorder involving systemic inflammatory symptoms, polyclonal lymphoproliferation, cytopenias, and multiple organ system dysfunction caused by a cytokine storm often including interleukin-6. iMCD accounts for one third to one half of all cases ofMCDand can occur in individuals of any age. Accurate diagnosis is challenging, because no standard diagnostic criteria or diagnostic biomarkers currently exist, and there is significant overlap with malignant, autoimmune, and infectious disorders. An international working group comprising 34 pediatric and adult pathology and clinical experts in iMCD and related disorders from 8 countries, including 2 physicians that are also iMCD patients, was convened to establish iMCD diagnostic criteria. The working group reviewed data from 244 cases, met twice, and refined criteria over 15 months (June 2015 to September 2016). The proposed consensus criteria require both Major Criteria (characteristic lymph node histopathology and multicentric lymphadenopathy), at least 2 of 11Minor Criteria with at least 1 laboratory abnormality, and exclusion of infectious, malignant, and autoimmune disorders that can mimic iMCD. Characteristic histopathologic featuresmay include a constellation of regressed or hyperplastic germinal centers, follicular dendritic cell prominence, hypervascularization, and polytypic plasmacytosis. Laboratory and clinical Minor Criteria include elevatedC-reactive protein or erythrocyte sedimentation rate, anemia, thrombocytopenia or thrombocytosis, hypoalbuminemia, renal dysfunction or proteinuria, polyclonal hypergammaglobulinemia, constitutional symptoms, hepatosplenomegaly, effusions or edema, eruptive cherry hemangiomatosis or violaceous papules, and lymphocytic interstitial pneumonitis. iMCD consensus diagnostic criteria will facilitate consistent diagnosis, appropriate treatment, and collaborative research.",
author = "Fajgenbaum, {David C.} and Uldrick, {Thomas S.} and Adam Bagg and Dale Frank and David Wu and Gordan Srkalovic and David Simpson and Liu, {Amy Y.} and David Menke and Shanmuganathan Chandrakasan and Lechowicz, {Mary Jo} and Wong, {Raymond S.M.} and Sheila Pierson and Michele Paessler and Rossi, {Jean Fran{\cc}ois} and Makoto Ide and Jason Ruth and Michael Croglio and Alexander Suarez and Vera Krymskaya and Amy Chadburn and Gisele Colleoni and Sunita Nasta and Raj Jayanthan and Nabel, {Christopher S.} and Corey Casper and Angela Dispenzieri and Alexander Foss{\aa} and Dermot Kelleher and Razelle Kurzrock and Peter Voorhees and Ahmet Dogan and Kazuyuki Yoshizaki and {Van Rhee}, Frits and Eric Oksenhendler and Jaffe, {Elaine S.} and Elenitoba-Johnson, {Kojo S.J.} and Lim, {Megan S.}",
year = "2017",
month = "3",
day = "23",
doi = "10.1182/blood-2016-10-746933",
language = "English (US)",
volume = "129",
pages = "1646--1657",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "12",

}

TY - JOUR

T1 - International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease

AU - Fajgenbaum, David C.

AU - Uldrick, Thomas S.

AU - Bagg, Adam

AU - Frank, Dale

AU - Wu, David

AU - Srkalovic, Gordan

AU - Simpson, David

AU - Liu, Amy Y.

AU - Menke, David

AU - Chandrakasan, Shanmuganathan

AU - Lechowicz, Mary Jo

AU - Wong, Raymond S.M.

AU - Pierson, Sheila

AU - Paessler, Michele

AU - Rossi, Jean François

AU - Ide, Makoto

AU - Ruth, Jason

AU - Croglio, Michael

AU - Suarez, Alexander

AU - Krymskaya, Vera

AU - Chadburn, Amy

AU - Colleoni, Gisele

AU - Nasta, Sunita

AU - Jayanthan, Raj

AU - Nabel, Christopher S.

AU - Casper, Corey

AU - Dispenzieri, Angela

AU - Fosså, Alexander

AU - Kelleher, Dermot

AU - Kurzrock, Razelle

AU - Voorhees, Peter

AU - Dogan, Ahmet

AU - Yoshizaki, Kazuyuki

AU - Van Rhee, Frits

AU - Oksenhendler, Eric

AU - Jaffe, Elaine S.

AU - Elenitoba-Johnson, Kojo S.J.

AU - Lim, Megan S.

PY - 2017/3/23

Y1 - 2017/3/23

N2 - Human herpesvirus-8 (HHV-8)-negative, idiopathic multicentric Castleman disease (iMCD) is a rare and life-threatening disorder involving systemic inflammatory symptoms, polyclonal lymphoproliferation, cytopenias, and multiple organ system dysfunction caused by a cytokine storm often including interleukin-6. iMCD accounts for one third to one half of all cases ofMCDand can occur in individuals of any age. Accurate diagnosis is challenging, because no standard diagnostic criteria or diagnostic biomarkers currently exist, and there is significant overlap with malignant, autoimmune, and infectious disorders. An international working group comprising 34 pediatric and adult pathology and clinical experts in iMCD and related disorders from 8 countries, including 2 physicians that are also iMCD patients, was convened to establish iMCD diagnostic criteria. The working group reviewed data from 244 cases, met twice, and refined criteria over 15 months (June 2015 to September 2016). The proposed consensus criteria require both Major Criteria (characteristic lymph node histopathology and multicentric lymphadenopathy), at least 2 of 11Minor Criteria with at least 1 laboratory abnormality, and exclusion of infectious, malignant, and autoimmune disorders that can mimic iMCD. Characteristic histopathologic featuresmay include a constellation of regressed or hyperplastic germinal centers, follicular dendritic cell prominence, hypervascularization, and polytypic plasmacytosis. Laboratory and clinical Minor Criteria include elevatedC-reactive protein or erythrocyte sedimentation rate, anemia, thrombocytopenia or thrombocytosis, hypoalbuminemia, renal dysfunction or proteinuria, polyclonal hypergammaglobulinemia, constitutional symptoms, hepatosplenomegaly, effusions or edema, eruptive cherry hemangiomatosis or violaceous papules, and lymphocytic interstitial pneumonitis. iMCD consensus diagnostic criteria will facilitate consistent diagnosis, appropriate treatment, and collaborative research.

AB - Human herpesvirus-8 (HHV-8)-negative, idiopathic multicentric Castleman disease (iMCD) is a rare and life-threatening disorder involving systemic inflammatory symptoms, polyclonal lymphoproliferation, cytopenias, and multiple organ system dysfunction caused by a cytokine storm often including interleukin-6. iMCD accounts for one third to one half of all cases ofMCDand can occur in individuals of any age. Accurate diagnosis is challenging, because no standard diagnostic criteria or diagnostic biomarkers currently exist, and there is significant overlap with malignant, autoimmune, and infectious disorders. An international working group comprising 34 pediatric and adult pathology and clinical experts in iMCD and related disorders from 8 countries, including 2 physicians that are also iMCD patients, was convened to establish iMCD diagnostic criteria. The working group reviewed data from 244 cases, met twice, and refined criteria over 15 months (June 2015 to September 2016). The proposed consensus criteria require both Major Criteria (characteristic lymph node histopathology and multicentric lymphadenopathy), at least 2 of 11Minor Criteria with at least 1 laboratory abnormality, and exclusion of infectious, malignant, and autoimmune disorders that can mimic iMCD. Characteristic histopathologic featuresmay include a constellation of regressed or hyperplastic germinal centers, follicular dendritic cell prominence, hypervascularization, and polytypic plasmacytosis. Laboratory and clinical Minor Criteria include elevatedC-reactive protein or erythrocyte sedimentation rate, anemia, thrombocytopenia or thrombocytosis, hypoalbuminemia, renal dysfunction or proteinuria, polyclonal hypergammaglobulinemia, constitutional symptoms, hepatosplenomegaly, effusions or edema, eruptive cherry hemangiomatosis or violaceous papules, and lymphocytic interstitial pneumonitis. iMCD consensus diagnostic criteria will facilitate consistent diagnosis, appropriate treatment, and collaborative research.

UR - http://www.scopus.com/inward/record.url?scp=85016255188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016255188&partnerID=8YFLogxK

U2 - 10.1182/blood-2016-10-746933

DO - 10.1182/blood-2016-10-746933

M3 - Article

C2 - 28087540

AN - SCOPUS:85016255188

VL - 129

SP - 1646

EP - 1657

JO - Blood

JF - Blood

SN - 0006-4971

IS - 12

ER -